{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-009798","form_type":"8-K","ticker":"GKOS","cik":"0001192448","company_name":"GLAUKOS Corp","filed_at":"2025-07-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.505447+00:00","generated_at":"2026-05-17T22:51:03.609990+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Glaukos Q2 record net sales $124.1M (+30% YoY); raises FY 2025 guidance to $480-486M","bullets":["Record net sales $124.1M, up 30% YoY; glaucoma sales $103.5M (+36%), U.S. glaucoma $72.3M (+45%).","Net loss narrowed to $19.7M ($0.34 per share) from $50.5M ($1.00); non-GAAP loss $13.6M ($0.24).","Gross margin ~78%, non-GAAP ~83%; cash & investments $278.6M, zero debt.","Raised 2025 net sales guidance to $480-486M (prior $475-485M); management cites sustained growth acceleration."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-009798","json":"https://secwatch.observer/filing/0001558370-25-009798.json","markdown":"https://secwatch.observer/filing/0001558370-25-009798.md","text":"https://secwatch.observer/filing/0001558370-25-009798.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1192448/000155837025009798/0001558370-25-009798-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1192448/000155837025009798/gkos-20250730x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T22:51:03.609990+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}